Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vion Pharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vion Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Vion Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is VION. The reporting company's CIK number is 944522.
The total value of stock buying since 2005 is $243,143.
The total value of stock sales since 2005 is $105,985.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2009-09-09||King Ivan (VP Research and Development)||Sale||45,166||1.09||49,366|
|2009-09-08||Cahill Ann Lee (VP Clinical Development)||Sale||70,000||.78||54,390|
|2007-03-15||Ryan Aileen (VP Regulatory Affairs)||Buy||1,500||1.68||2,520|
|2007-03-13||Rakin Kevin (Director)||Buy||15,000||1.59||23,850|
|2007-03-12||Bickerstaff George (Director)||Buy||50,000||1.76||87,750|
|2007-03-09||Williams Ian (Director)||Buy||5,000||1.66||8,300|
|2007-03-08||Johnson Howard B (President and CFO)||Buy||12,800||1.55||19,891|
|2007-03-07||Willis Gary K (Director)||Buy||50,000||1.52||76,000|
|2007-03-07||Kessman Alan (Chief Executive Officer)||Buy||16,000||1.55||24,832|
|2005-09-12||Kessman Alan (Chief Executive Officer)||Sale||791||2.82||2,229|
Insider trading activities including stock purchases, stock sales, and option exercises of VION listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vion Pharmaceuticals Inc (symbol VION, CIK number 944522) see the Securities and Exchange Commission (SEC) website.